report
clinic
featur
discharg
patient
recoveri
analysi
indic
signific
invers
correl
exist
serum
ddimer
level
durat
antivir
treatment
lymphocyt
concentr
significantli
posit
correl
durat
viru
revers
sinc
dec
th
mani
case
report
investig
describ
clinic
characterist
hospit
patient
infect
notic
recent
report
lan
et
al
medic
staff
still
viru
carrier
recoveri
infect
gave
report
discharg
patient
medic
record
review
analysi
patient
infect
hospit
jan
th
feb
th
met
follow
criteria
hospit
discharg
china
day
normal
signific
reduct
respiratori
symptom
substanti
improv
convent
chest
radiographi
detect
consecut
twice
neg
result
rtpcr
test
interv
least
day
consid
risk
reinfect
selfsegreg
home
observ
realtim
rtpcr
detect
perform
describ
previous
demograph
clinic
radiolog
laboratori
find
extract
electron
medic
record
patient
studi
approv
shenzhen
third
peopl
hospit
ethic
committe
inform
consent
waiv
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
day
two
consecut
neg
result
viru
mrna
rtpcr
detect
well
improv
chest
comput
tomographi
ct
evid
cloacal
swab
sampl
rest
nasal
swab
oropharynx
swab
sampl
test
patient
present
repeat
posit
mrna
within
day
hospit
notabl
median
time
last
neg
result
turn
posit
day
patient
hospit
continu
quarantin
protocol
patient
asymptomat
chest
ct
scan
indic
even
show
improv
rest
repres
obviou
chang
compar
previou
imag
day
prophylact
intervent
chines
herbal
medicin
rtpcr
result
viru
mrna
detect
turn
neg
nasopharyng
swab
cloacal
swab
sampl
furthermor
correl
analysi
indic
signific
invers
correl
exist
serum
ddimer
level
durat
antivir
treatment
lymphocyt
concentr
significantli
posit
correl
durat
viru
revers
impli
imperfect
antiviru
therapi
probabl
respons
recurr
viru
patient
infect
met
criteria
hospit
releas
quarantin
rtpcr
test
convers
posit
without
symptom
day
asymptomat
carrier
brought
challeng
manag
control
epidem
china
affect
countri
got
glanc
factor
associ
clearanc
due
lack
antivir
drug
confirm
effici
possibl
immunolog
paramet
could
use
addit
indic
properli
assess
viru
activ
need
prolong
quarantin
asymptomat
patient
casecontrol
studi
cohort
studi
need
pursu
indic
role
author
contribut
dr
yanchao
pan
lei
liu
full
access
data
studi
take
respons
integr
data
accuraci
data
analysi
acquisit
analysi
interpret
data
jing
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
data
given
mean
standard
deviat
sd
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
figur
correl
analysi
lymphocyt
count
durat
viru
revers
well
serum
ddimer
level
durat
antivir
treatment
correl
analysi
serum
ddimer
level
durat
antivir
treatment
well
correl
lymphocyt
concentr
significantli
durat
viru
revers
b
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
